K-Stat 250 Tablet
By K-Stat
Rx
10 Tablet in a Strip

Composition
Ethamsylate(250mg)

Manufacturer - Mercury Laboratories Ltd
12-B, Girichhaya, Loyalka Estate, Chowpatty Band Stand, Mumbai - 400 006. INDIA

Expires on or after
August, 2025

liver
There is limited information available regarding the safety of using K-Stat 250 Tablet in individuals with liver disease. It is essential to seek guidance from your doctor before starting this medication if you have any liver concerns. Your healthcare provider can evaluate your specific situation and provide appropriate advice tailored to your health needs. Consulting with your doctor is crucial to ensure the safe and effective use of K-Stat 250 Tablet.

kidney
Limited information is available on using K-Stat 250 Tablet in kidney disease patients. It is advised to consult with your doctor.

alcohol
Consult your doctor when consuming alcohol with K-Stat 250 Tablet.

driving
K-Stat 250 Tablet does not typically impact driving ability.

pregnancy
K-Stat 250 Tablet may not be safe during pregnancy. Limited human studies suggest potential harm to the baby. Animal studies show harmful effects on fetal development. Your doctor will assess risks versus benefits before prescribing. Please consult your doctor before using it.

breastfeeding
It is better to consult your doctor before using K-Stat 250 Tablet during breastfeeding.
Habit Forming | No |
Chemical Class | Benzenesulfonate Derivative |
Therapeutic Class | BLOOD RELATED |
Action Class | Haemostatic agent |
₹140
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 11-Feb-2025